Sahajanand Medical Technologies Limited (SMT) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Sahajanand Medical Technologies Limited on NSE and BSE, with an AI summary of each filing.
Announcement under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 04 Nov 2026, 10:35 pm
Sahajanand Medical Technologies Receives GST Demand Recovery Notice Worth Rs 34.3 Lakh Sahajanand Medical Technologies received a GST recovery notice in Form GST DRC-01D on 4th Nov'26 from the Joint Commissioner of State Tax, Ranchi, demanding Rs 34,29,789 (including interest and penalty) for FY19 to FY21. The dispute pertains to Input Tax Credit eligibility under the cross-charge mechanism following DRC-07 orders issued on 22nd Jul'22. The company has litigated the matter before appellate authorities and confirmed that the notice has no material financial, operational, or business impact.
Intimation of upgradation of Credit Rating under Regulation 30 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 04 Nov 2026, 9:19 pm
CRISIL Upgrades Credit Ratings for Sahajanand Medical Technologies and Subsidiary CRISIL Ratings has upgraded Sahajanand Medical Technologies Ltd's bank facilities rating to 'CRISIL A-/Stable/CRISIL A2+' from 'CRISIL BBB+/Stable/CRISIL A2', enhancing rated limits to Rs 300 crore. Subsidiary SMT Cardiovascular's rating was upgraded to 'CRISIL BBB+/Stable' from 'CRISIL BBB/Stable'. The upgrade reflects a strengthened business risk profile following an 18% YoY operating revenue increase to Rs 1,214.14 crore and a PAT surge to Rs 69.08 crore in FY26, supported by stable operating margins (13.14%) and a healthy capital structure with gearing at 0.43x.